Uncategorized
Ideas and explainers on the samples that help researchers ask better questions.
Tagrisso: The Tumor Biopsy That Turned Lung Cancer Into a Targeted Disease
Introduction Lung cancer has long been one of the deadliest cancers worldwide, but not all lung cancers are the same disease at the molecular level. In roughly 15% of non-small cell lung cancer (NSCLC) cases, the most common form, accounting for about 85% of all lung cancer diagnoses, the tumor's growth is driven by mutations…
Casgevy (CRISPR Gene-Editing Therapy): Sickle Cell, the Disease that Medicine Forgot for a Century
Forward In 2020, the world lost an amazing man, Mark Drafton, to a blood clot. I was fortunate to work alongside Mark for several years leading up to his passing and in that time, he shared with me many of his experiences of living with Sickle Cell Disease (SCD). Despite the challenges to his health,…

Humira (Adalimumab): The Joint Fluid that Found a Disease's Hidden Driver and the Patent Cliff that Followed
In the early 1990s, rheumatoid arthritis (RA) was treated with blunt tools like steroids, NSAIDs, and methotrexate, none targeting the actual cause. Researchers studying synovial fluid and blood samples from RA patients found something consistent: abnormally high levels of a cytokine called TNF-alpha, sitting right in the inflamed joint tissue. Why the Samples Were Essential…

Gleevec (Imatinib): The Chromosome that Named its Own Drug
In the early 1970s, researchers studying bone marrow and blood samples from chronic myeloid leukemia (CML) patients noticed something strange under the microscope…an abnormally short chromosome 22. It was named, “The Philadelphia chromosome,” after the city where it was discovered by David Hunderford (a graduate student/research fellow) and Peter Nowell (a pathologist), who identified the…

Herceptin (Trastuzumab): The Gene that Turned a Death Sentence into a Treatable Disease
In the 1980s, breast cancer treatment was largely a one-size-fits-all approach. And then, researchers studying tumor tissue biopsies noticed something unusual: in roughly 1 in 5 patients, tumor cells had far too many copies of a gene called HER2/neu. This wasn’t a minor detail. Patients with HER2-amplified tumors, identified through paraffin-embedded and frozen tissue samples,…